Blossomhill Therapeutics, Inc. (BLSM)
26.68
+0.94
(+3.65%)
USD |
NASDAQ |
Sep 21, 16:00
26.13
-0.55
(-2.06%)
After-Hours: 20:00
Blossomhill Therapeutics Total Assets (Quarterly) : 124.13M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 124.13M |
| Date | Value |
|---|---|
| March 31, 2026 | 143.41M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| IGC Pharma, Inc. | 9.496M |
| Cocrystal Pharma, Inc. | 4.649M |
| CNBX Pharmaceuticals, Inc. | 0.0128M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 675.10M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 298.91M |
| Shareholders Equity (Quarterly) | -174.78M |
| Debt to Equity Ratio | -1.603 |
| Current Ratio | 5.261 |